JEFFREY KITCH: Open Payments
NPI 1518107275 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 51 payments from 16 companies in 2025. Trend: 2023 $1,878 · 2024 $987 · 2025 $917
Food & beverage: $897Education: $20
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $240 |
| E.R. Squibb & Sons, L.L.C. | 16 | $216 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| PFIZER INC. | 3 | $65 |
| Boston Scientific Corporation | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
Products named: CAMZYOS, VERQUVO, WINREVAIR, ELIQUIS, Kerendia, WATCHMAN FLX, LEQVIO, Wegovy.
Industry payments across LA — which companies pay providers there.
